Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +8.6%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 601–650 of 732 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00774046	High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML	completed	Phase 2	32	University of ChicagoOTHER	1	Feb 11, 2014	clinicaltrials
NCT00016016	Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia	completed	Phase 1 / Phase 2	53	National Cancer Institute (NCI)NIH	1	Oct 8, 2013	clinicaltrials